$CRTG
CORETEC GROUP INC. Stock $crtg

$crtg Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924016428 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$234.8K	$358.1K
YoY Change	-23.23%	3.14%
% of Gross Profit
Research & Development	$59.80K	$122.5K
YoY Change	-50.76%	9.43%
% of Gross Profit
Depreciation & Amortization	$24.61K	$3.960K
YoY Change	6.81%	66.88%
% of Gross Profit
Operating Expenses	$59.80K	$122.5K
YoY Change	-50.76%	9.43%
Operating Profit
YoY Change
Interest Expense	$39.78K	$44.52K
YoY Change	-24.73%	-17.68%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$334.2K	-$524.2K
YoY Change	-29.53%	3.32%
Income Tax
% Of Pretax Income
Net Earnings	-$334.2K	-$524.2K
YoY Change	-29.53%	3.32%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	315.0M	301.4M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.440K	$115.1K
YoY Change	-99.69%	-94.08%
Cash & Equivalents	$4.437K	$115.1K
Short-Term Investments
Other Short-Term Assets	$285.3K	$88.29K
YoY Change	806.16%	55.8%
Inventory
Prepaid Expenses	$35.26K	$88.29K
Receivables
Other Receivables
Total Short-Term Assets	$289.7K	$203.4K
YoY Change	-80.45%	-89.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$101.8K	$105.8K
YoY Change	-7.49%	48.84%
Goodwill	$166.0K	$166.0K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.550K	$4.550K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$1.055M	$1.080M
YoY Change	-7.93%	-4.25%
TOTAL ASSETS
Total Short-Term Assets	$289.7K	$203.4K
Total Long-Term Assets	$1.055M	$1.080M
Total Assets	$1.345M	$1.283M
YoY Change	-48.81%	-58.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$252.5K	$154.7K
YoY Change	-19.71%	-55.17%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$48.18K
YoY Change		55.92%
Long-Term Debt Due	$1.486M	$476.1K
YoY Change		602.78%
Total Short-Term Liabilities	$1.599M	$679.0K
YoY Change	408.38%	52.99%
LONG-TERM LIABILITIES
Long-Term Debt	$389.5K	$1.010M
YoY Change	-73.09%	-25.95%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$389.5K	$1.010M
YoY Change	-73.09%	-25.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.599M	$679.0K
Total Long-Term Liabilities	$389.5K	$1.010M
Total Liabilities	$1.988M	$1.689M
YoY Change	12.84%	-6.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.51M	-$19.18M
YoY Change	12.61%	13.79%
Common Stock	$67.35K	$60.27K
YoY Change	18.92%	12.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$643.0K	-$405.1K
YoY Change
Total Liabilities & Shareholders Equity	$1.345M	$1.283M
YoY Change	-48.81%	-58.97%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$334.2K	-$524.2K
YoY Change	-29.53%	3.32%
Depreciation, Depletion And Amortization	$24.61K	$3.960K
YoY Change	6.81%	66.88%
Cash From Operating Activities	-$312.5K	-$361.7K
YoY Change	-26.04%	-5.4%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	201.8K	-$47.20K
YoY Change	-780.67%	54.74%
NET CHANGE
Cash From Operating Activities	-312.5K	-$361.7K
Cash From Investing Activities	0.000
Cash From Financing Activities	201.8K	-$47.20K
Net Change In Cash	-110.6K	-$408.9K
YoY Change	-77.58%	-0.96%
FREE CASH FLOW
Cash From Operating Activities	-$312.5K	-$361.7K
Capital Expenditures	$0.00
Free Cash Flow	-$312.5K
YoY Change	-32.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	358095	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	347194	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	524256	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	803688	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	824345	usd
CY2024Q1	us-gaap	Goodwill Goodwill	166000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	166000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4550	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4550	usd
CY2024Q1	crtg	Assets Excluding Property And Equipment Noncurrent AssetsExcludingPropertyAndEquipmentNoncurrent	974238	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	656668	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	203365	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	105806	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109766	usd
CY2023Q4	crtg	Assets Excluding Property And Equipment Noncurrent AssetsExcludingPropertyAndEquipmentNoncurrent	994895	usd
CY2024Q1	us-gaap	Assets Assets	1283409	usd
CY2023Q4	us-gaap	Assets Assets	1761329	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	154727	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	75918	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	571451	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	678983	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	647369	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1009542	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1003816	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1688525	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1651185	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0002
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0002
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	345000
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	345000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	345000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	345000
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	69	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	69	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	301368572
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	301368572
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	284104032
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	284104032
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	60272	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	56819	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18711715	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18706208	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19177172	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18652952	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-405116	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	110144	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1283409	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	usd
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001375195
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1761329	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	122454	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	111902	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	44518	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	54081	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	525067	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	513177	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	847	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5793	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-524220	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-507384	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.002
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.002
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	292909312
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	268871202
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	110144	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	8960	usd
CY2024Q1	crtg	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-524220	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-405116	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1828320	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-507384	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1320936	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-524220	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-507384	usd
CY2024Q1	us-gaap	Depreciation Depreciation	3960	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2373	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20657	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20658	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5726	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	16267	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-44388	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-57533	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	87769	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	28169	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-361720	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-382384	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	47195	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	30498	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47195	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30498	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-408915	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-412882	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	523988	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2356348	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	115073	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1943466	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1653	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	33439	usd
CY2024Q1	crtg	Stock Issued To Settle Liabilities From Services Received StockIssuedToSettleLiabilitiesFromServicesReceived	8960	usd
CY2023Q1	crtg	Stock Issued To Settle Liabilities From Services Received StockIssuedToSettleLiabilitiesFromServicesReceived	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	608319	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	587662	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</p>
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	803688	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	248521697
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	254942697
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	824345	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21385	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17425	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	105806	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109766	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1009542	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1003816	usd
CY2024Q1	crtg	Amortization Associated With Commitment Fee AmortizationAssociatedWithCommitmentFee	1688	usd
CY2023Q1	crtg	Amortization Associated With Commitment Fee AmortizationAssociatedWithCommitmentFee	4337	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	476075	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	870000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	139542	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1485617	usd
CY2020Q2	crtg	Share Exchange Agreement Number Of Options Authorized ShareExchangeAgreementNumberOfOptionsAuthorized	21500000
CY2020Q2	crtg	Share Exchange Agreement Exchange Ratio ShareExchangeAgreementExchangeRatio	0.6	rate
CY2024Q1	crtg	Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged	9500000
CY2024Q1	crtg	Stock Issued During Period Shares Stock Options Exchanged For Common Shares StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares	5700000
CY2024Q1	crtg	Stock Issued During Period Shares Stock Options Exchanged For Common Shares StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares	5700000
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2814000
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	120014000
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0612
CY2023	crtg	Class Of Warrant Or Right Contractual Term ClassOfWarrantOrRightContractualTerm	P2Y7M17D
CY2024Q1	crtg	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	14921000
CY2024Q1	crtg	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.0001
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	105093000
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0699
CY2024Q1	crtg	Class Of Warrant Or Right Contractual Term ClassOfWarrantOrRightContractualTerm	P2Y4M13D
CY2024Q1	crtg	Class Of Warrant Or Right Intrinsic Value ClassOfWarrantOrRightIntrinsicValue	267313	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	101158160
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.059
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3000000
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.024
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	98158160
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.06
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M1D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	98158160
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.06
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M1D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	98158160
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y11M1D
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	98158160
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	14600	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	13650	usd

Files In Submission

Name	View Source	Status
0001437749-24-016428-index-headers.html	Edgar Link	pending
0001437749-24-016428-index.html	Edgar Link	pending
0001437749-24-016428.txt	Edgar Link	pending
R5.htm	Edgar Link	pending
0001437749-24-016428-xbrl.zip	Edgar Link	pending
crtg-20240331.xsd	Edgar Link	pending
crtg20240331_10q.htm	Edgar Link	pending
crtg20240331_10qimg013.jpg	Edgar Link	pending
ex_671083.htm	Edgar Link	pending
ex_671084.htm	Edgar Link	pending
ex_671085.htm	Edgar Link	pending
ex_671086.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
crtg-20240331_pre.xml	Edgar Link	unprocessable
crtg-20240331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crtg20240331_10q_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
crtg-20240331_cal.xml	Edgar Link	unprocessable
crtg-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTG
CORETEC GROUP INC. Stock $crtg

2024 Q2 Form 10-Q Financial Statement

#000143774924016428 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTG CORETEC GROUP INC. Stock $crtg

2024 Q2 Form 10-Q Financial Statement

#000143774924016428 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTG
CORETEC GROUP INC. Stock $crtg